Professional Documents
Culture Documents
JEADV 2020
Author Num. of Age Gender Duration of Previous treatment Location PDT sessions Photosensitizer Outcome Recurrence and
patients (average) (M/F) disease follow up (months)
(years) months
(range)
Kim3, 2006 1 25 F 3 – Hands 4 20% 5-ALA Complete remission No recurrence
7
Hanneken4, 2008 1 40 F 12 Topical corticosteroids Lower limbs 9-13 20% 5-ALA Complete remission –
Weisenseel6, 2008 7 55 4/3 48 (4-108) Topical corticosteroids: Hands: n = 4 2.4 20% 5-ALA Complete remission: –
100% (n = 7) Lower limbs: n = 1 28.57% (n = 2) 6
Ultaviolet treatment: Lower arm: n = 1 Improvement:
27.14% (n = 4) Elbow: n = 1 28.57% (n = 2)
Oral corticosteroids: No change: 42.85%
28,57 (n = 2) (n = 3)
Piaserico5, 2009 3 53 2/1 80(36–108) 1 patient: Topical Generalized GA 3 (n = 2) MAL Complete remission: n = 1 –
corticosteroids and 5 (n = 1) Improvement: n = 2 6
tacrolimus
1 patient: Topical, oral
and intralesional
corticosteroids, and
hydroxicloroquine
1 patient: Topical
corticosteroids and
tacrolimus
Calzavara-Pinton7, 13 50.8 (9.8) 5/8 – – – 2.8 1.4 MAL Marked improvement: –
2012 53.8% (n = 7) 7.3 8.4
Moderate: 15% (n = 2)
No change: 31% (n = 4)
Garcia-Malinis, 2020 13 53 2/11 24 (1–72) Topical corticosteroids: Hands: 53,9% 3.15 2.7 MAL: 76,9% Complete remission: 61,5% (n = 8);
(15) 100% (n = 13) (n = 7) (n = 10) 53.8% (n = 7) 35 25.34
Tacrolimus: 23.1% Lower limbs: 20% 5-ALA: Improvement: 30.8% (n = 4)
(n = 3) 30,8 (n = 4) 15,4% (n = 2) No change: 15.4% (n = 2)
Hydroxicloroquine: Upper limbs: Both: 7,7%
15.4% (n = 2) 7,7% (n = 1) (n = 1)
Cryotherapy: 15.4% Trunk: 7,7%
(n = 2) (n = 1)
Pentoxifylline: 30.8%
(n = 4) Oral corticosteroids:
38.15% (n = 5)
Letter to the Editor
Figure 1 (a) Granuloma annulare (GA) in lower limbs. (b) Fluorescence before photodynamic therapy (PDT) session. (c) Hyperpigmenta-
tion 1 month later after two sessions of PDT separated by 4 weeks. (d) Complete resolution of GA